Experimental Basis Sets of Quantification of Brain H-Magnetic Resonance Spectroscopy at 3.0 T

Overview

Journal Metabolites

Publisher MDPI

Date 2023 Mar 29

PMID 36984808

Authors

Hyeon-Man Baek

Affiliations

Soon will be listed here.

Abstract

In vivo short echo time (TE) proton magnetic resonance spectroscopy (H-MRS) is a useful method for the quantification of human brain metabolites. The purpose of this study was to evaluate the performance of an in-house, experimentally measured basis set and compare it with the performance of a vendor-provided basis set. A 3T clinical scanner with 32-channel receive-only phased array head coil was used to generate 16 brain metabolites for the metabolite basis set. For voxel localization, point-resolved spin-echo sequence (PRESS) was used with volume of interest (VOI) positioned at the center of the phantoms. Two different basis sets were subjected to linear combination of model spectra of metabolite solutions in vitro (LCModel) analysis to evaluate the in-house acquired in vivo H-MR spectra from the left prefrontal cortex of 22 healthy subjects. To evaluate the performance of the two basis sets, the Cramer-Rao lower bounds (CRLBs) of each basis set were compared. The LCModel quantified the following metabolites and macromolecules: alanine (Ala), aspartate (Asp), γ-amino butyric acid (GABA), glucose (Glc), glutamine (Gln), glutamate (Glu), glutathione (GHS), Ins (myo-Inositol), lactate (Lac), N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG), taurine (Tau), phosphoryl-choline + glycerol-phosphoryl-choline (tCho), N-acetylaspartate + N-acetylaspartylglutamate (tNA), creatine + phosphocreatine (tCr), Glu + Gln (Glx) and Lip13a, Lip13b, Lip09, MM09, Lip20, MM20, MM12, MM14, MM17, Lip13a + Lip13b, MM14 + Lip13a + Lip13b + MM12, MM09 + Lip09, MM20 + Lip20. Statistical analysis showed significantly different CRLBs: Asp, GABA, Gln, GSH, Ins, Lac, NAA, NAAG, Tau, tCho, tNA, Glx, MM20, MM20 + Lip20 ( < 0.001), tCr, MM12, MM17 ( < 0.01), and Lip20 ( < 0.05). The estimated ratio of cerebrospinal fluid (CSF) in the region of interest was calculated to be about 5%. Fitting performances are better, for the most part, with the in-house basis set, which is more precise than the vendor-provided basis set. In particular, Asp is expected to have reliable CRLB (<30%) at high field (e.g., 3T) in the left prefrontal cortex of human brain. The quantification of Asp was difficult, due to the inaccuracy of Asp fitting with the vendor-provided basis set.

References

Brambilla P, Stanley J, Sassi R, Nicoletti M, Mallinger A, Keshavan M . 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology. 2004; 29(10):1918-24. DOI: 10.1038/sj.npp.1300520. View

Wilson M, Davies N, Sun Y, Natarajan K, Arvanitis T, Kauppinen R . A comparison between simulated and experimental basis sets for assessing short-TE in vivo ¹H MRS data at 1.5 T. NMR Biomed. 2010; 23(10):1117-26. DOI: 10.1002/nbm.1538. View

Deelchand D, Adanyeguh I, Emir U, Nguyen T, Valabregue R, Henry P . Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T. Magn Reson Med. 2014; 73(5):1718-25. PMC: 4272339. DOI: 10.1002/mrm.25295. View

Provencher S . Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001; 14(4):260-4. DOI: 10.1002/nbm.698. View

van der Graaf M, Julia-Sape M, Howe F, Ziegler A, Majos C, Moreno-Torres A . MRS quality assessment in a multicentre study on MRS-based classification of brain tumours. NMR Biomed. 2007; 21(2):148-58. DOI: 10.1002/nbm.1172. View

Yue Q, Liu M, Nie X, Wu Q, Li J, Zhang W . Quantitative 3.0T MR spectroscopy reveals decreased creatine concentration in the dorsolateral prefrontal cortex of patients with social anxiety disorder. PLoS One. 2012; 7(10):e48105. PMC: 3479123. DOI: 10.1371/journal.pone.0048105. View

Marjanska M, Deelchand D, Kreis R . Results and interpretation of a fitting challenge for MR spectroscopy set up by the MRS study group of ISMRM. Magn Reson Med. 2021; 87(1):11-32. PMC: 8616800. DOI: 10.1002/mrm.28942. View

Tkac I, Starcuk Z, Choi I, Gruetter R . In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 1999; 41(4):649-56. DOI: 10.1002/(sici)1522-2594(199904)41:4<649::aid-mrm2>3.0.co;2-g. View

Deelchand D, Iltis I, Henry P . Improved quantification precision of human brain short echo-time (1) H magnetic resonance spectroscopy at high magnetic field: a simulation study. Magn Reson Med. 2013; 72(1):20-5. PMC: 3907456. DOI: 10.1002/mrm.24892. View

10.

Provencher S . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993; 30(6):672-9. DOI: 10.1002/mrm.1910300604. View

11.

Kaiser L, Young K, Matson G . Numerical simulations of localized high field 1H MR spectroscopy. J Magn Reson. 2008; 195(1):67-75. PMC: 2585774. DOI: 10.1016/j.jmr.2008.08.010. View

12.

Mosconi E, Sima D, Osorio Garcia M, Fontanella M, Fiorini S, Van Huffel S . Different quantification algorithms may lead to different results: a comparison using proton MRS lipid signals. NMR Biomed. 2014; 27(4):431-43. DOI: 10.1002/nbm.3079. View

13.

Murphy P, Viviers L, Abson C, Rowland I, Brada M, Leach M . Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. Br J Cancer. 2004; 90(4):781-6. PMC: 2410174. DOI: 10.1038/sj.bjc.6601593. View

14.

Brambilla P, Stanley J, Nicoletti M, Sassi R, Mallinger A, Frank E . 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord. 2005; 86(1):61-7. DOI: 10.1016/j.jad.2004.12.008. View

15.

Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C . Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med. 2004; 51(5):904-12. DOI: 10.1002/mrm.20063. View

16.

Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D . Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed. 2005; 18(1):1-13. DOI: 10.1002/nbm.895. View

17.

Govindaraju V, Young K, Maudsley A . Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3):129-53. DOI: 10.1002/1099-1492(200005)13:3<129::aid-nbm619>3.0.co;2-v. View

18.

Bottomley P . Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987; 508:333-48. DOI: 10.1111/j.1749-6632.1987.tb32915.x. View

19.

Horder J, Lavender T, Mendez M, OGorman R, Daly E, Craig M . Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study. Transl Psychiatry. 2013; 3:e279. PMC: 3731785. DOI: 10.1038/tp.2013.53. View

20.

Mandal P . In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites. Eur J Radiol. 2011; 81(4):e653-64. DOI: 10.1016/j.ejrad.2011.03.076. View